<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2018-09-17</periodOfReport>

    <noSecuritiesOwned>1</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001461993</issuerCik>
        <issuerName>MELINTA THERAPEUTICS, INC. /NEW/</issuerName>
        <issuerTradingSymbol>MLNT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001531049</rptOwnerCik>
            <rptOwnerName>Milligan Peter J</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O MELINTA THERAPEUTICS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>300 GEORGE STREET, SUITE 301</rptOwnerStreet2>
            <rptOwnerCity>NEW HAVEN</rptOwnerCity>
            <rptOwnerState>CT</rptOwnerState>
            <rptOwnerZipCode>06511</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Financial Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <footnotes></footnotes>

    <remarks>The Reporting Person was appointed as the new Chief Financial Officer of the Issuer, effective as of September 17, 2018.</remarks>

    <ownerSignature>
        <signatureName>/s/ Peter Milligan</signatureName>
        <signatureDate>2018-09-24</signatureDate>
    </ownerSignature>
</ownershipDocument>
